The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Shafer Bradford J since 2006.
The trader's CIK number is 1302448.
At the time of the last reporting, Shafer Bradford J was the Sr VP, Gen. Counsel, of Theravance Biopharma, Inc.. (stock ticker symbol TBPH).
Also see all insider trading activities at Theravance Biopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | THRX | 0 | $0 | 93,962 | $3,056,174 | 130,440 | $1,426,717 |
| 2013 | THRX | 0 | $0 | 31,038 | $1,087,571 | 0 | $0 |
| 2011 | THRX | 0 | $0 | 46,689 | $1,027,308 | 30,205 | $257,648 |
| 2008 | THRX | 0 | $0 | 34,676 | $553,671 | 0 | $0 |
| 2007 | THRX | 0 | $0 | 50,000 | $1,275,153 | 0 | $0 |
| 2006 | THRX | 0 | $0 | 0 | $0 | 40,761 | $236,902 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | TBPH | 0 | $0 | 52,459 | $1,409,501 | 0 | $0 |
| 2017 | TBPH | 0 | $0 | 41,499 | $1,306,122 | 0 | $0 |
| 2016 | TBPH | 0 | $0 | 49,122 | $1,348,896 | 0 | $0 |
2. Theravance Biopharma, Inc. (TBPH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-11 | THRX | Option Ex | 33,667 | 14.53 | 489,181 |
| 2014-08-11 | THRX | Sale | 27,108 | 22.12 | 599,628 |
| 2014-08-12 | THRX | Sale | 1,048 | 22.30 | 23,370 |
| 2014-03-03 | THRX | Option Ex | 96,773 | 9.69 | 937,536 |
| 2014-03-03 | THRX | Sale | 65,806 | 36.98 | 2,433,176 |
| 2013-06-07 | THRX | Sale | 31,038 | 35.04 | 1,087,571 |
| 2011-11-28 | THRX | Option Ex | 30,205 | 8.53 | 257,648 |
| 2011-11-28 | THRX | Sale | 20,000 | 21.00 | 420,000 |
| 2011-03-11 | THRX | Sale | 26,689 | 22.75 | 607,308 |
| 2008-07-30 | THRX | Sale | 34,676 | 15.97 | 553,671 |
| 2007-10-31 | THRX | Sale | 25,000 | 25.00 | 625,000 |
| 2007-08-01 | THRX | Sale | 7,300 | 26.40 | 192,705 |
| 2007-08-01 | THRX | Sale | 16,200 | 25.86 | 418,996 |
| 2007-08-01 | THRX | Sale | 1,500 | 25.64 | 38,452 |
| 2006-05-03 | THRX | Option Ex | 40,761 | 5.81 | 236,902 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-27 | TBPH | Sale | 7,119 | 27.71 | 197,281 |
| 2018-08-07 | TBPH | Sale | 5,945 | 28.51 | 169,503 |
| 2018-08-08 | TBPH | Sale | 25,355 | 27.85 | 706,187 |
| 2018-06-06 | TBPH | Sale | 10,140 | 24.09 | 244,272 |
| 2018-06-08 | TBPH | Sale | 3,900 | 23.66 | 92,258 |
| 2017-09-06 | TBPH | Sale | 14,670 | 30.77 | 451,351 |
| 2017-03-03 | TBPH | Sale | 26,829 | 31.86 | 854,771 |
| 2016-08-18 | TBPH | Sale | 7,174 | 28.55 | 204,817 |
| 2016-08-19 | TBPH | Sale | 4,870 | 28.14 | 137,041 |
| 2016-08-22 | TBPH | Sale | 37,078 | 27.16 | 1,007,038 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shafer Bradford J (Sr VP, Gen. Counsel, of Theravance Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.